| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Medicines for Europe Medicines for Europe began over 20 years ago as the European Generics Medicines Association (EGA) with the goal of representing the emerging generic industry, and later growing to include biosimilar medicines to its portfolio. As the pharmaceutical industry and the healthcare environment within which it operates have evolved, so has our Association. When the association was first launched back in 1993, generic alternatives to branded medicines made up a fraction of the market. As more of these medicines came off-patent, and the benefits and value of generics to both patients and healthcare providers became clearer, so the provision of generic … | 4 | 0 | 6 | 51 |
 | DCAT (Drug, Chemical & Associated Technologies Association) The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into … Type: | 6 | 0 | 6 | 35 |
 | Value Edge Value Edge Research is a global business research, market intelligence, market research and sales analytics company providing support and outsourcing solutions to global bio-pharma companies. We are known for the high quality of our deliverables driven by a highly talented and experienced team from blue chip life science companies and life science solution providers. The firm's custom research and analytics and proprietary research reports and databases to global life science clients are highly cost effective. Value Edge is headquartered in India and the US office is located in the Greater Boston Area. For more information on Value Edge and its … Type: | 16 | 2 | 6 | 22 |
 | Giphar [Automatic translation follows] Let's take your health to heart Created in 1968, Giphar (Independent Group of Independent Pharmacists) is the leader in under-brand pharmacy networks on the French market. Giphar in figures: • 1,250 pharmacies, 1,800 pharmacists • 1st pharmacy brand in France according to the latest LSA ranking • 2.3 billion euros in turnover • 5 pharmaceutical statuses: Wholesaler Distributor, Depositary, Pharmaceutical Laboratory, Pharmaceutical Purchasing Center and Medicine Broker • 4 warehouses: Grandvilliers (60), Castelaneau-le-lez (34), Angers (49) and Dijon (21) • 2 brands: Libeoz (medical equipment for autonomy and mobility), Laboratoire Giphar (para-pharmacy) But Giphar is also men … Type: | 8 | 1 | 6 | 382 |
 |  Medsii.com Medsii.com is a UK B2B HealthTech Delivering Regulatory-Grade Medicines Intelligence Faster. Medsii.com is the flagship product of PharmaSentinel, a UK B2B HealthTech Providing Targeted Medicines Intelligence for Pharmaceuticals, Biotechs, Clinicians and Industry Analysts. Our flagship app Medsii.com (also on the App Store & Play Store) leverages AI to offer more accurate and more efficient information management, giving our customers a competitive edge. Our solution is already being used by leading pharmaceutical companies. #Pharmaceuticals #Medicines #RegulatoryInformation #ClinicalInformation #DigitalSolutions HealthTech, Digital Health, Startup, and AI Type: | 6 | 0 | 6 | 1 |
 | Gilbert Good health starts with you Since 1904, Gilbert, a French industrial group, has been operating in the fields of pharmaceuticals, cosmetics, hygiene, CDMO and spas & institutes, in order to offer health solutions that respect human and his environment. . With a portfolio of nearly 50 brands - including the Laboratoires Gilbert brand - exported to 86 countries, the Gilbert group occupies leading positions in the fields of health, and in particular in France in the field of baby products for which he is number 1 in pharmacy sales. Gilbert employs more than 1,000 people in its laboratories and its … Type: | 8 | 1 | 6 | 498 |
 | Vetter Pharma Your partner in aseptic filling and packaging We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and … Type: | 9 | 2 | 6 | 1,921 |
 | ISPE Connecting Pharmaceutical Knowledge ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA and the Operations and Training Center in Tampa, Florida, USA. Pharmaceutical Education and Training, Pharmaceutical Guidance Documents, Pharmaceutical Professional Community Building/Networking, Career Solutions, Drug … Type: | 12 | 3 | 6 | 442 |
 |  Vaxxel The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin Type: | 6 | 0 | 6 | 11 |
 | SGD Pharma Pharmaceutical Glass Packaging Solutions SGD Pharma has unique know-how and offers innovative premium quality primary packaging compliant with international pharmacopoeias. From design to manufacturing, our teams will support you in the development and implementation of your project. SGD Pharma’s corporate quality policy is applied in all of its manufacturing facilities and is compliant with pharmaceutical Good Manufacturing Practices (GMPs). Recognizing that the patient is the end user of its products, SGD Pharma implements the strictest quality standards. All of our manufacturing sites are fully dedicated to pharmacy and are according to ISO 15378 standards. Each of our vials is inspected … Type: | 7 | 1 | 6 | 1,071 |
 | MSD Deutschland [Automatic translation follows] Inventing for life. At MSD, known in the US and Canada as Merck & Co., Inc., Rahway, NJ, USA, we are united by one goal: We use leading scientific findings to save lives and enable a better quality of life around the world. We have been representing progress through the development of important new medications and vaccines for over 130 years. Our aim is to be a global leader as a research-based biopharmaceutical company - and we develop innovative health solutions and active ingredients that further improve the prevention and treatment of diseases in humans and animals. … Type: | 7 | 1 | 6 | 1,953 |
 | Chiesi Group International pharmaceutical Group certified B Corp. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high … Type: | 11 | 3 | 6 | 5,331 |
 | pharma.be pharma.be is the federation of 130+ innovative pharmaceutical companies active in Belgium. pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 128 companies and 42.000 employees active in human healthcare in Belgium. As a full partner of physicians, pharmacists, hospitals, governments and other stakeholders, pharma.be has the mission to promote better health care through therapeutic innovation in the domain of medicinal products for human and veterinary use. Therefore, the top priority is to ensure that patients have the fastest possible access to innovative medicines resulting from research and development. Twitter: https://twitter.com/pharmabe and @CarolineVen Website: www.pharma.be Pharmaceutical industry Type: | 6 | 1 | 6 | 50 |
 | TransCelerate BioPharma Inc. TransCelerate is a non-profit organization with a mission to collaborate across the biopharmaceutical R&D community. TransCelerate BioPharma Inc. was launched in 2012 as a non-profit organization to improve the health of people around the world by accelerating and enhancing the research and development of innovative new therapies. Our mission is to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines. Our membership is made up of 20+ of the world’s most innovative and successful biopharmaceutical organizations who provide … Type: | 9 | 0 | 7 | 85 |
 | Egualia – Industrie Farmaci Accessibili A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and … Type: | 7 | 0 | 7 | 18 |
 | GIRP - European Healthcare Distribution Association GIRP, the European Healthcare Distribution Association, is the umbrella organisation for full-service healthcare distributors in Europe. It represents the national associations of over 750 pharmaceutical wholesalers serving 34 European countries, as well as major international and pan-European healthcare distribution companies. GIRP members employ over 140,000 people and distribute around 15 billion packs of medicines as well as a wide range of healthcare products per year. As the vital link in healthcare, they are committed to developing and providing innovative and efficient healthcare products and services to improve health and wellbeing of patients across Europe. GIRP members employ over 140,000 people … Type: | 12 | 0 | 7 | 11 |
 | ESTEVE Advancing health together At ESTEVE we have a clear purpose: to improve people's lives. We are an international specialty pharmaceutical company with pharma affiliates in Spain, Germany, France, UK, Portugal and Italy. We also have industria sites dedicated to the development and manufacture of active pharmaceutical ingredients in Spain, Mexico and China. Together we work to meet the unmet medical needs of our patients through innovative solutions that are environmentally sustainable, while remaining true to our values in everything we do: people matter, transparency and accountability. Because we care not only about what we do, but also about how we … Type: | 11 | 1 | 7 | 1,744 |
 | TrialCard TrialCard is now Mercalis. Please follow our new LinkedIn page: https://www.linkedin.com/company/mercalisinc TrialCard became Mercalis on September 20, 2023. Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace … Type: | 7 | 0 | 7 | 680 |
 | CHPA CHPA is the 141-year-old national trade association representing the leading manufacturers and marketers of OTC meds. Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $7.33, contributing a total of $167 billion in savings each year. CHPA is committed to promoting the increasingly vital role of OTC medicines and dietary supplements in America’s healthcare system through science, education, and advocacy. Visit www.chpa.org to learn more. Over-the-counter … Type: | 7 | 0 | 7 | 124 |
 | HealthCare Institute of New Jersey (HINJ) Advancing Global Health - Leading New Jersey's Economy The HealthCare Institute of New Jersey (HINJ) serves as the voice for the research-based biopharmaceutical and medical technology industry in New Jersey. HINJ seeks to expand patient access to the most innovative biopharmaceuticals, medical technologies and devices, and diagnostics tools and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being. Please visit www.hinj.org or follow us on Twitter @ HINJ_ORG, Facebook @ HealthCareInstituteofNewJersey and LinkedIn @HealthCareInstituteOfNewJersey. To learn more about the Life Sciences’ significant impact on New Jersey’s economy, please visit New Jersey’s Life Sciences: By … Type: | 6 | 0 | 7 | 7 |
 | Creapharm, a Myonex company Creapharm, a Myonex company, offers capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing advanced therapies. Beyond decades of experience in Clinical Trial Supply Management, we provide a strong expertise in cold-chain management and recently developed ultra-cold solutions to handle biologicals and ATMP supply chain. For marketed health products, we offer expert commercial packaging services. More globally, Myonex is established throughout Europe (France, Germany and Denmark), UK and in the USA. Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP Sourcing and Importation, and Biological sampling kit production | 11 | 2 | 7 | 137 |
 | Fresenius Kabi FR [Automatic translation follows] Fresenius Kabi is a global healthcare company specializing in life-saving medicines and medical devices in infusion, transfusion and clinical nutrition. Fresenius Kabi's medicines, technologies and services are used to help care for patients in emergency situations or with chronic illnesses. Fresenius Kabi's product portfolio includes a full range of generic intravenous medications, infusion therapies, clinical nutrition products as well as the medical devices required to administer these products. In the biosimilars space, we focus on autoimmune diseases and oncology. In 2019, Fresenius Kabi's first biosimilar product was launched. In the field of transfusion medicine and cell therapies, … Type: | 8 | 1 | 7 | 447 |
 | Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … Type: | 7 | 0 | 7 | 112 |
 | CYBERNANO Optimize your product development, Quality by Design for all ! CYBERNANO aims to support pharmaceutical, biotech and medtech companies in the Quality-by-Design (QbD) process. The use of QbD is necessary in these high accuracy industries to predict and avoid risks from the early stage of an innovant project. In order to democratize the QbD approach, which requires a lot of effort and expertise, CYBERNANO offers a QbD semi-automated* SaaS platform : « easyQBD ». *(an expert perspective combined to the efficacy of the platform) CYBERNANO a pour vocation d’accompagner les entreprises des secteurs pharmaceutiques, biotechnologiques et des technologies médicales dans … Type: | 8 | 0 | 7 | 6 |
 | Hermandad Farmaceutica del Mediterraneo, S.C.L. [Automatic translation follows] Hefame Group Hefame is a cooperative pharmaceutical distribution company founded in 1950. The third company in its sector in the country by turnover volume, in 2021 it exceeded 1,455 million euros. Hefame, today, has the best and most efficient logistics platforms and regulatory warehouses with more than 80,000 m2. Currently, the cooperative has more than 1,000 employees and serves more than 6,000 pharmacies, with nearly 48,000 daily orders and 10,000 daily deliveries. This is possible thanks to its great infrastructure, with distribution warehouses and offices in Albacete, Alicante, Almería, Barcelona, Cartagena, Castellón, Girona, Granada, Madrid, Málaga, Melilla, … Type: | 11 | 3 | 7 | 514 |
 | Sanofi Polska [Automatic translation follows] We chase the miracles of science to improve people's lives. Sanofi is an innovative, global biopharmaceutical company with one goal: to change the world for the better, in accordance with the slogan "We chase the miracles of science to improve people's lives", relying on the power of science. In 100 countries, committed and talented teams are working to change the face of medicine, making the impossible possible. The company creates therapies and vaccines that save the lives of millions of people around the world. We have a wide range of specialized medicinal products and services in many … Type: | 7 | 0 | 7 | 173 |
 | UPSA [Automatic translation follows] We place people at the heart of our action to support all moments of life. The UPSA laboratory places people at the heart of its action to support all moments of life. Founded in 1935, UPSA is today both a company, with one of the largest pharmaceutical industrial sites in Europe located in Agen, and a brand committed and present in the daily lives of patients and pharmacists. Through its range of family medications, UPSA develops, manufactures and provides medicines to relieve pain and minor everyday ailments, from babies to the elderly and also markets medical devices. … Type: | 12 | 6 | 7 | 1,277 |
 | Organon France [Automatic translation follows] Official page of Organon France. Improving the health of every woman and making every day a better day. International pharmaceutical laboratory, leader in women's health and major player in the provision of biosimilar drugs and historic drugs with high public health issues. For more information, go to www.organon.fr or follow us on https://twitter.com/OrganonFrance To contact our medical information service: ☎️ 01 57 77 32 00 📩 info.medicale.fr@organon.com Type: | 8 | 2 | 7 | 117 |
 | ApconiX Nonclinical safety experts asking the right questions at the right time to make safer, more effective drugs ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety. The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs who also … Type: | 7 | 0 | 7 | 53 |
 | Diversity Alliance for Science The LIFE SCIENCE/ HEALTHCARE Organization to get involved in! Since 2008, Diversity Alliance for Science has been the pre-eminent networking organization for life science companies and diverse-certified suppliers to connect, collaborate and drive the value of diversity. Our networking events are about genuine connections and finding the best way to spark innovation through building business relationships on our diverse perspectives. Our suppliers and corporations build their bottom lines by keeping our shared goals in mind: all the work they produce contributes to making medicines, devices, and ideas that save lives. The best way to get to know our organization is … Type: | 7 | 0 | 7 | 10 |
 | Pharmacy Quality Alliance Optimizing health by advancing the quality of medication use Optimizing Health by Advancing the Quality of Medication Use. quality measures, measure development, medication use, and medication safety Type: | 8 | 0 | 8 | 47 |
 | DIA Empower healthcare innovation with DIA Experience the power of collaborative innovation with DIA (Drug Information Association)!Since 1964, our passionate, volunteer-based global network works together to provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments. Join our dynamic, nonprofit organization that serves as a hub for life sciences professionals, academia, advocates, and policymakers worldwide. At DIA, we foster interdisciplinary connections, engaging patients, peers, and visionary leaders in tackling today's challenges and shaping tomorrow's breakthroughs. Unleash your potential with our knowledge resources, … Type: | 11 | 2 | 8 | 461 |
 | OPPI India Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare … Type: | 8 | 1 | 8 | 15 |
 | CQDM Facilitateur d'innovation biopharma // Facilitator of biopharma innovation Facilitator of biopharma innovation // Facilitateur d'innovation biopharma. CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM receives financial support from pharmaceutical companies Amgen, AstraZeneca, GSK, Merck, Pfizer, Roche, Sanofi, Servier, Takeda as well as from Quebec’s Ministère de l'Économie, l'Innovation et de l'Énergie (MEIE). For more information: www.cqdm.org. Le CQDM est un consortium pharmaceutique actif … Type: | 8 | 2 | 8 | 30 |
 | CREATION.co Better listening for better health We’ve worked in the healthcare sector for more than two decades. In 2012, we developed CREATION Pinpoint – a unique technology platform allowing us to isolate conversations among healthcare professionals, meaning we cut out 95% of the chatter, and focus only on the conversations that matter. CREATION Pinpoint is a proprietary technology platform that uses machine learning to find, listen to and understand what is being said by doctors, nurses, and pharmacists, alongside a team of knowledge engineers who analyze the data to develop customized research insights. The technology maps peer-to-peer relationships between healthcare professionals … Type: | 11 | 0 | 8 | 111 |
 | Seratec [Automatic translation follows] Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. Drawing on internationally recognized French know-how, we design, develop, produce and register files of pharmacologically active molecules. with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to quality standards known as Good Manufacturing Practices (GMP 2 or … Type: | 8 | 0 | 8 | 25 |
 | SYNSIGHT Drug discovery from inside the cell We aim to make Drug Discovery faster, cheaper and smarter ! Early-Stage Drug Discovery includes many Design-and-Test cycles. A large Pharma company may go through 25 cycles or more in a single year! This is where Synsight comes in: we help our clients and partners to make focused decisions on which molecules to make; how and why certain molecules exert a biological activity (or fail to); how to enhance the activity or selectivity of lead molecules, or make them more drug-like; and even how to find new indications for known drugs. criblage virtuel, modélisation … Type: | 10 | 1 | 8 | 8 |
 | MediLedger Frictionless Business - We are creating a healthcare ecosystem without administrative costs through a connected industry The MediLedger Project is a collaboration between Chronicled and The LinkLab, bringing together expertise in both Pharmaceutical Supply Chain and Blockchain technologies. Our intention is to advance the dialogue of a blockchain utility to enhance Pharma companies’ ability to manage their supply chains. We believe a Pharma industry blockchain utility and ecosystem can: Improve compliance of track and trace regulations Improve patient safety and drug supply security Enable easier reconciliation of exceptions Provide a platform for further business transformation for processes associated with the … Type: | 8 | 0 | 8 | 1 |
 | House of Pharma & Healthcare [Automatic translation follows] Research - train - talk to each other The House of Pharma & Healthcare was founded in 2013 and is based in Frankfurt am Main. It wants to sharpen the profile of Hesse and Germany as a pharmaceutical and healthcare location and make it visible worldwide. To this end, it promotes cooperation between all players in the healthcare and pharmaceutical industries in Germany. It sees itself as a network of public-private partnerships that connects various interests along the pharmaceutical value chain in order to develop solutions to the challenges in the healthcare system. Accordingly, it involves business, … Type: | 8 | 0 | 8 | 6 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: | 10 | 4 | 8 | 8 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action. It is demonstrated that one endogenous protease called tissue plasminogen activator (tPA) is implicated in the pathophysiology of neurological diseases such as multiple sclerosis, Parkinson’s disease, stroke and other neurodegenerative disorders through its overexpression and binding to NMDA receptors (NMDAr) present on vascular endothelial cells and regulating the blood brain barrier (BBB) function / … Type: | 13 | 4 | 8 | 12 |
 | Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: | 10 | 3 | 8 | 7 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | Arkopharma Faire de la Médecine Naturelle la Médecine de Demain. Arkopharma is a pharmaceutical company founded in 1980 in Carros, near Nice (France), that specializes in the area of phytotherapy, natural medicine and nutritional supplements. Arkopharma is now the European leader in plant-based medicine and nutritional supplements, with an international presence in more than 60 countries. Arkopharma has a dual aim: • To provide natural medicines both for treatment and prevention • To offer healthcare professionals new options for advice and prescriptions Arkopharma in figures: • 1501 employees • 201.3 million euros of consolidated sales • 1,853 registrations and MAs (marketing … Type: | 19 | 7 | 9 | 820 |
 | National Pharmaceutical Council Health policy research on value, evidence, innovation & access for patients. The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. NPC's research helps to inform many critical health care policy debates and supports the organization's overall goal of achieving the best patient outcomes in the most efficient way possible. Over the years, the issues we have focused on have evolved along with the changes in the health care environment and pharmaceutical industry. NPC’s current research examines the … | 9 | 0 | 9 | 24 |
 | IPHA #InnovateForLife We represent the inventors of medicines to prevent, treat and, sometimes, cure diseases. Through science, we extend how long people live and how well they can live. Type: | 9 | 0 | 9 | 20 |
 | Trialbee The Leading Enrollment Performance Company Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey PlatformTM is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment – providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step … Type: | 10 | 0 | 9 | 75 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 13 | 5 | 9 | 89 |
 | Aptys pharma The formulation company APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery. APTYS offers ISO9001 aligned contract service, according to cGMP. Custom-made formulation development including in vivo/in vitro assessments. Semi solid dosage forms for topical and transdermal delivery. Injectable peptide depot formulations. Analytical development and validations. Quality control and ICH stability. Type: | 9 | 1 | 9 | 19 |
 | Skyepharma Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms. Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms. We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services. Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial … Type: | 13 | 5 | 9 | 208 |
 | Teva Santé [Automatic translation follows] Who is Teva Health? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of medicines, generic or not, allows the treatment of more than 120 pathologies. In France, its medicines concern one in 12 prescriptions. But Teva's involvement goes well beyond just medicine. Its action is part of commitments in favor of patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify themselves, understand and master their role, … Type: | 12 | 1 | 9 | 261 |
 | AKTEHOM [Automatic translation follows] An Ambition for Life At the crossroads of scientific expertise and regulatory advice, AKTEHOM supports pharmaceutical and biotechnology manufacturers in the control and understanding of products and processes with an objective of quality and performance to guarantee patient safety. AKTEHOM has a strong identity, focused on customer relations and the well-being of its employees, which is added to proven expertise. The pleasure of bringing value to our clients, carrying out their projects and succeeding together guides our team of 50 people on a daily basis. AKTEHOM intervenes in particular in the following areas: - Product/Precedence Mastery: implementation … Type: | 10 | 1 | 9 | 58 |
 |  Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: | 13 | 4 | 9 | 46 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 14 | 6 | 10 | 119 |
 | URGO Group [Automatic translation follows] Invent & Care The URGO Group is committed every day to changing the lives of patients, by putting science at the service of therapeutic progress. It supports healthcare professionals to promote best care practices. 2 PROFESSIONS URGO MEDICAL Faced with the explosion of chronic diseases such as diabetes, Urgo Medical responds to a growing need for care of serious and disabling wounds. We help patients heal better, faster, by developing solutions that have proven their superiority in clinical studies. HEALTHCARE In order to allow everyone to become an actor in their health, our Urgo Healthcare, Juva Santé … Type: | 23 | 7 | 10 | 2,663 |
 | Unither Pharmaceuticals A world-leading pharmaceutical contract development manufacturing organization (CDMO). Unither Pharmaceuticals, with 8 manufacturing plants (France, USA, Brazil and China) 4 commercial offices and 1 R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing. Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Multidoses with and without preservative, Pharmaceuticals bottles, Suppositories and Pessaries, etc. Our products are sold in more than 100 countries for an annual turnover of 371 million euros. Our vision is to be recognized for making affordable healthcare solutions that improve … Type: | 16 | 5 | 10 | 1,282 |
 | EFPIA - European Federation of Pharmaceutical Industries and Associations Illness never sleeps, so neither can we #WeWontRest The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu Pharmaceutical Industry Type: | 13 | 3 | 11 | 135 |
 | Cyclamed [Automatic translation follows] The Cyclamed association, approved by the public authorities, has the mission of collecting and recycling Unused Medicines (UNM) for human use, expired or not, returned by patients to pharmacies. Its objective is to secure the disposal of Unused Medicines, in order to preserve the environment and public health. To these ends, Cyclamed carries out awareness and communication actions among the general public, health professionals and environmental stakeholders. The “Cyclamed Reflex” is a gesture that must be obvious and therefore become a natural gesture. Cyclamed is a non-profit association under the 1901 law bringing together the entire pharmaceutical … Type: | 13 | 4 | 11 | 9 |
 | OCP Répartition [Automatic translation follows] Leader & Reference for the Pharmacy of Tomorrow OCP at the heart of the health chain OCP is both the leader and the historical referent (1924) of pharmaceutical distribution in France. By providing pharmaceutical logistics and efficient services, OCP is the essential link between laboratories and pharmacists. Every day we contribute to better health. With a territorial network of 41 establishments in France, OCP holds nearly 32% market share and distributes 2 million boxes of medications every day to 16,000 customer pharmacies (including 2,000 hospital pharmacies), from a range of 36,000 references available. OCP is the first … Type: | 14 | 3 | 11 | 1,359 |
 | Eisai US Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related … Type: | 17 | 2 | 11 | 2,988 |
 | GIE GERS - Groupement pour l'Elaboration et la Réalisation de Statistiques [Automatic translation follows] The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. For 45 years, GERS has supported its members in market analysis and performance management and offers unique comprehensive data by pooling data on medicines and health products. GERS plays a key role in the conventional system and economic regulation of reimbursable and hospital medicines. Sell In data is used by health authorities to monitor key market indicators, determine the drug pricing policy based on the level of … Type: | 16 | 3 | 12 | 8 |
 | LFB Un groupe pharmaceutique spécialiste des médicaments issus du vivant LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies. With a sustained investment in … Type: | 18 | 2 | 12 | 2,258 |
 | Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … Type: | 12 | 1 | 12 | 843 |
 | Veracyte Biopharma Services Gain actionable insights to confidently advance every step of your oncology drug development programs. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs. precision medicine, Biopharma, biomarker signatures, and Cancer care Type: | 18 | 6 | 13 | 93 |
 | CNS Summit Collaborating for Novel Solutions! Now in our 14th year, CNS Summit was created by life science leaders to advance clinical development, with a focus on collaboration, innovation, and technology. The CNS Summit is a community of innovators and industry leaders who are not afraid to challenge the status quo. CNS Summit convenes 1000+ decision-makers from organizations involved in clinical development, healthcare innovation, regulatory authorities, investigator sites, and service companies. At CNS Summit, you will experience emerging technologies with practical applications, curated networking and idea sharing, and create collaborative opportunities to propel the future of drug development. You will return to … Type: | 13 | 0 | 13 | 672 |
 | Polepharma La Fabrique [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Pharmaceutical industry and Healthcare industry Type: | 14 | 4 | 13 | 3 |
 | Vereniging Innovatieve Geneesmiddelen [Automatic translation follows] Medicines for tomorrow. The Association for Innovative Medicines represents pharmaceutical companies that are involved in the development and marketing of new and innovative medicines. These are medicines that provide answers to new insights into the treatment of diseases or to conditions that have so far been untreatable. Association Innovative Medicines on Twitter: https://twitter.com/wewordenbeter And on Facebook: https://nl-nl.facebook.com/wewordenbeter advocacy, innovation, (bio)pharmaceutical sector, research, and medicines Type: | 14 | 1 | 14 | 44 |
 | AIS Congress The major mAb Event in France ! We are proud to announce the 10th Antibody Industrial Symposium 2022 (AIS2022) will be held on June 28-29th 2022 in Montpellier, France. This congress, jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign, is part of the series of Industrial Symposia organized by MAbImprove since 2013 (Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates, Targets for mAbs, Harnessing the Immune System). mAbs, Immunotherapy, Industry, Innovation, Research, drugdiscovery, networking, and B2B Type: | 15 | 3 | 14 | 1 |
 | Chiesi España [Automatic translation follows] As a B Corp company, we are driven by the #purpose of improving the quality of #people's lives. #SomosChiesi Chiesi is an international research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialty care. Our mission is to improve people's quality of life and act responsibly for the benefit of the community and the environment. By changing its legal status to Charitable Corporation in Italy, the US and France, Chiesi's commitment to creating shared value for society as a whole is legally binding and central to the company's decision making. … Type: | 15 | 1 | 16 | 257 |
 | Horus Pharma Horus Pharma is an independent French laboratory specialised in ophthalmology. Founded in 2003, Horus Pharma develops, patents and markets products designed to facilitate eye and eyelid health. Horus Pharma operates in most segments related to ophthalmology and develops practical innovations that combine efficacy and safety. Read our community guidelines https://bit.ly/HPCommunityGuidelines Focused on patient safety, our laboratory has developed recognised expertise in the development of preservative-free formulations and product delivery systems. The product portfolio at the laboratory includes medicinal products, medical devices and food supplements. With its new Surgery Division, Horus Pharma is pursuing its growth by offering surgical and peri-surgical … Type: | 18 | 3 | 16 | 243 |
 | G5 Santé [Automatic translation follows] Think tank which brings together the main French health and life sciences companies. The G5 health is a think tank, which brings together the main French health and life sciences companies. BioMérieux, Guerbet, Ipsen, LFB, Pierre Fabre, Sanofi, Servier and Théa are companies that have chosen France as a platform for international development and have made research efforts a priority. On a global scale, the G5 health is a major player with a turnover of more than 47 billion euros and investing more than 7 billion euros in R&D. Type: | 21 | 8 | 16 | 4 |
 | WuXi AppTec The global pharmaceutical and medical device open-access capability and technology platform As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing … Type: | 18 | 1 | 17 | 4,347 |
 | Reuters Events Pharma Our mission is to make pharma more open and valued. Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals … Type: | 19 | 3 | 18 | 14 |
 | The Association of the British Pharmaceutical Industry (ABPI) Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner … Type: | 25 | 2 | 18 | 112 |
 | Association Tulipe [Automatic translation follows] Responding to health emergencies around the world Tulipe is the emergency and international solidarity association of health companies. A non-governmental organization governed by the law of 1901, Tulipe brings together donations from health companies to respond, urgently, to the needs of populations in distress, during acute health crises, natural disasters and conflicts. Its intervention then takes the form of making available, within very short deadlines, emergency kits of new health products, adapted to the needs of the field. Medicine Donations, Humanitarian Organization, International Emergency, Healthcare Business CSR, and Medical Device Donations Type: | 20 | 2 | 20 | 19 |
 | PharmaBoardroom The ultimate resource for Healthcare & Life Sciences leaders worldwide Pharma Boardroom is the ultimate resource for Healthcare & Life Sciences leaders worldwide. We're your dedicated source for in-depth insights into both local and global markets. Our teams connect with key stakeholders in person, covering every corner of the globe. We go where others don't, conducting face-to-face meetings with industry influencers to deliver unparalleled perspectives on market dynamics. Our commitment to understanding the unique challenges and opportunities in various regions sets us apart. In an ever-evolving healthcare landscape, our extensive network allows you to access firsthand experiences from peers in … Type: | 21 | 0 | 21 | 12 |
 | Fédération Française des Industries de Santé - FEFIS [Automatic translation follows] The ambition to put its action at the service of public health policy, a source of social and economic progress. Created in 1975, the French Federation of Health Industries – Féfis – brings together eleven professional organizations representing companies which create, manufacture or distribute health products such as human and veterinary medicines, medical devices, optical products, dental products, in vitro diagnostics. A crossroads for exchanges and common actions, Féfis strives to be the spokesperson for a strategic sector of the future for the growth and competitiveness of our country. His commitments within numerous structures – ARIIS, MEDEF, … Type: | 26 | 6 | 21 | 6 |
 | Cercle de Réflexion de l'Industrie Pharmaceutique (CRIP Pharma) [Automatic translation follows] A collective of pharmaceutical company managers on a human scale. CRIP Pharma, a think tank generating ideas to contribute to the evolution of the health environment. CRIP Pharma is leading discussions on the central place of digital technology in the evolution and transformation of the pharmaceutical sector: - A means to develop professions in the sector - Its impact on the health ecosystem, serving the patient, but also to reinvent the interactions between the different actors - A tool to accelerate and maximize efficiency in the sector, from R&D to the patient journey - From denial to … Type: | 26 | 4 | 22 | 14 |
 | The Pharmaceutical Managers Institute We strive to support our members ongoing learning, growth and professional development in a rapidly evolving industry. The PMI is a professional membership organisation dedicated to the continuous learning, development and support of those working in management within the pharmaceutical industry. Our membership is diverse, covering Commercial, Marketing, Market Access, Product Management and Regulatory roles; representating over 80 pharmaceutical organisations. The Institute has been built on 3 pillars, which are central to all the events and activities we run throughout the year. With our four different event series - Pharma Leaders, Pharma Managers, Women in Leadership and Masterclasses - we … Type: | 22 | 0 | 22 | 10 |
 | Pharmaceutical Commerce Magazine Pharmaceutical Commerce is dedicated to the commercial operations of the North American pharmaceutical industry. Four times a year, its 16,000 executive readers get the latest information and analysis commercial operations, marketing/sales best practices, supply chain management, product packaging and security, information technology and legal/regulatory services. The magazine covers the flow of products into distribution channels, the flow of information between the industry and healthcare providers, and the flow of funds in trading and payer agreements. pharma logistics (including cold chain), medication adherence, sales operations, multichannel marketing, PDMA compliance and more, life sciences, pharma, supply chain, supply chain logistics, pharmaceutical manufacturing, … Type: | 23 | 1 | 22 | 35 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 33 | 12 | 25 | 69 |
 | NovAliX NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand … Type: | 27 | 4 | 25 | 379 |
 | Butterfly Therapeutics (Previously Lucine) The medical device to relieve your pelvic perineal pain. Lucine is part of Butterfly Therapeutics since december 2023. Lucine is an expert in women’s pelvic pain relief, and we’re on a mission to change women’s lives. We offer an evidence-based approach with scientifically proven solutions that reduce & relieve pain related to endometriosis, periods, menopause, post-partum discomfort, and more. Endocare is our clinically-tested, patented medical device that directly targets pain mechanisms with a unique combination of visual and sound frequencies Let's work together, changing women's lives ! Pain, Digital therapeutics, Data, AI, Neurosciences, Sociology, Addiction, Health, Hospital, and CBT Type: | 37 | 15 | 26 | 23 |
 | POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: | 48 | 27 | 27 | 28 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 32 | 11 | 27 | 33 |
 | SEQENS Our science for your future SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies. … Type: | 34 | 8 | 28 | 1,272 |
 | Eli Lilly and Company For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly’s social … Type: | 60 | 16 | 33 | 42,831 |
SMB